交易 Bristol Myers BMY

出售
 購買

BristolMyers實時圖表

5m 15m 30m 1h 4h 1d 1w

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%)： 開倉 高 低

BristolMyers 新聞

盧昕穎 2025 Aug 22, 13:10

鮑威爾傑克遜霍爾演講：聯準會利率展望與川普壓力

陳昊然 2025 Aug 22, 10:10

麗莎·庫克身陷風暴：聯準會理事面臨抵押貸款詐欺指控與政治壓力

林芷柔 2025 Aug 22, 09:10

鮑威爾在傑克遜霍爾的講話：聯準會是否會暗示降息？

盧昕穎 2025 Aug 22, 08:10

小型股命懸一線：鮑爾傑克森霍爾講話逼近

黃達傑 2025 Aug 21, 16:00

PTIX 股價飆升 105%：Protagenic Therapeutics 發生了什麼事？

黃達傑 2025 Aug 17, 16:00

QUBT 收入下降：2025 年 QUBT 股票的預測

黃達傑 2025 Aug 12, 16:00

AI股票CFD：交易NVDA股票CFD， 交易AMD股票CFD

黃達傑 2025 Aug 11, 16:00

觀察的納斯達克100指數ETF：QQQ、QQQM、TQQQ

黃達傑 2025 Aug 10, 16:00

加密市場波動性：AERO 價格上漲 30%，Solana 超過 $182

黃達傑 2025 Aug 07, 16:00

Fortinet 股票崩潰：為什麼 Fortinet 股票 (FTNT) 今天下跌？

最新新聞

顯示更多
許景桓 2025 Aug 22, 15:20

市場回顧與投資洞察：2025 年 8 月

張瑋庭 2025 Aug 22, 15:20

川普威脅解僱聯準會理事庫克，起因抵押貸款詐欺指控

盧昕穎 2025 Aug 22, 15:20

華爾街反應：鮑威爾暗示九月可能降息，但態度謹慎

張瑋庭 2025 Aug 22, 14:20

外匯期權顯示鮑威爾講話前美元看漲情緒升溫

陳昊然 2025 Aug 22, 12:20

敘利亞貨幣改革：刪除貨幣面額上的零以恢復信心

林芷柔 2025 Aug 22, 10:20

印度與俄羅斯擴大貿易合作，無視美國關稅壓力

林芷柔 2025 Aug 22, 08:20

特朗普政府考慮挪用晶片法案資金用於關鍵礦產

林芷柔 2025 Aug 22, 08:20

鮑爾在傑克遜霍爾的演講：在經濟不確定性中塑造聯準會的未來

聯絡方式

點差

0.29

點差(%)

0.6081 %

槓桿

1:10

隔夜利息（買入）

-0.0597 %

隔夜利息（賣出）

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

97538277376

流通股份

2035440000

收益日期（下一個）

2001-08-07

現金殖利率 

2025-08-01

除息日

2025-07-03

遠期年股息率

2.48

遠期年現金殖利率

0.0518

每股盈餘

2.49

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%)：

立即交易

立即交易

立即交易

立即交易
查看所有金融工具

最新教育文章

顯示更多
黃達傑 2025 Aug 20, 16:00

比特幣 CFD 交易基礎：如何買賣比特幣 (BTC/USD) CFD？

黃達傑 2025 Aug 19, 16:00

Invesco QQQ Trust 今天下跌：QQQ 會回升嗎？

黃達傑 2025 Aug 18, 16:00

如何交易 US100 指數：US100 指數 CFD 交易的在線經紀商

Trustpilot